20.09.2007 11:00:00
|
Hi-Tech Pharmacal to Present at the UBS Global Life Sciences Conference
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that it is
scheduled to make an investor presentation at the UBS Global Life
Sciences Conference. David Seltzer, President and Chief Executive
Officer, will deliver the Company's presentation on Tuesday, September
25, 2007, at 10:00 a.m. Eastern Time. The conference is being held
September 24 - 27, 2007, at The Grand Hyatt Hotel, New York, New York.
A live audio webcast of the Company's presentation can be accessed on
the Company’s website: http://www.hitechpharm.com.
The webcast will be archived within 24 hours after the live event and
will be available for 30 days.
About Hi-Tech Pharmacal
Hi-Tech Pharmacal is a specialty pharmaceutical company developing,
manufacturing and marketing generic and branded products. The Company
specializes in difficult to manufacture liquid and semi-solid dosage
forms and produces a range of sterile ophthalmic, otic and inhalation
products. The Company’s Health Care Products
Division is a leading developer and marketer of branded prescription and
OTC products for the diabetes marketplace.
Forward-looking statements (statements which are not historical facts)
in this Press Release are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Forward-looking
statements are not promises or guarantees and investors are cautioned
that all forward-looking statements involve risks and uncertainties,
including but not limited to the impact of competitive products and
pricing, product demand and market acceptance, new product development,
the regulatory environment, including without limitation, reliance on
key strategic alliances, availability of raw materials, fluctuations in
operating results and other results and other risks detailed from time
to time in the Company's filings with the Securities and Exchange
Commission. These statements are based on management's current
expectations and are naturally subject to uncertainty and changes in
circumstances. We caution you not to place undue reliance upon any such
forward looking statements which speak only as of the date made. Hi-Tech
is under no obligation to, and expressly disclaims any such obligation
to, update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Hi-Tech Pharmacal Co. Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |